Cervical cancer is the fourth most frequently occurring cancer in women around the world
and can affect them during their reproductive years. Since the development of the …

Cervical cancer screening will rely, increasingly, on HPV testing as a primary screen. The
requirement for triage tests which can delineate clinically significant infection is thus …

Objective Thirteen human papillomavirus (HPV) genotypes are associated with the highest
risk of cervical disease/cancer; however, the risk of disease progression and cancer is …

Background To conduct a meta-analysis of performance of DNA methylation in women with
high-grade cervical intraepithelial neoplasia (CIN2+). Methods Medline and Embase …

Importance Triage tests enhance the efficiency cervical cancer screening based on human
papillomavirus (HPV), but the best approach for maximizing programmatic effectiveness is …

In the coming decade, primary testing for human papillomavirus (HPV) will likely become the
standard of care for cervical cancer screening in both low-and high-resource settings. This …

The performance of different clinical screening algorithms comprising point-of-care HPV-
DNA testing using self-collected vaginal ('V') specimens, and visual inspection of the cervix …

While cervix screening using cytology is recommended at 2‐to 3‐year intervals, given the
increased sensitivity of human papillomavirus (HPV)‐based screening to detect precancer …

We conducted a prospective randomized controlled trial with two screening rounds to
evaluate the effectiveness of combining HPV testing with liquid‐based cytology (LBC) as a …

Most women positive for human papillomavirus (HPV) are cytology normal. The optimal
screen‐management of these women is unclear given their risk of developing precancer …